Is the active ingredient.
Treatment of negative and positive symptoms of schizophrenia.
Treatment of depressive episodes associated with schizophrenia.
Treatment of moderate to severe manic episodes in bipolar I disorder.
Joypride 100mg Tab (Amisulpride) is an atypical antipsychotic that primarily acts as a dopamine D2 receptor antagonist in the mesolimbic pathway, reducing positive symptoms of psychosis. It also possesses some serotonin 5-HT2A receptor antagonism, potentially contributing to its efficacy in treating negative symptoms and improving mood.
Store in a cool, dry place away from direct sunlight and moisture. Keep out of reach of children. Dispose of unused medication responsibly.
Dosage should be determined by a healthcare professional and adjusted based on individual needs and response to treatment.
Dosage typically starts low and is gradually increased.
Amisulpride is usually administered orally, once or twice daily with or without food.
Extrapyramidal symptoms (EPS) such as akathisia, Parkinsonism, dystonia, and tardive dyskinesia.
Hyperprolactinemia (increased prolactin levels) leading to galactorrhea, amenorrhea, gynecomastia.
Sedation or drowsiness.
Weight gain.
Orthostatic hypotension.
Nausea, vomiting, constipation.
Dizziness.
Alcohol should be avoided or consumed in moderation as it can potentiate the sedative effects of amisulpride.
Avoid driving or operating machinery until the effects of the medication are known, as drowsiness and dizziness can occur.
Use during pregnancy and breastfeeding is generally avoided unless the benefits clearly outweigh the potential risks. Discuss with your doctor.
Not recommended for use in children unless specifically prescribed by a pediatrician and under strict monitoring.
Dosage adjustment may be necessary in patients with kidney impairment.
Dosage adjustment may be necessary in patients with liver impairment.
Please consult your prescribing physician or pharmacist for detailed information and references. Always refer to the official drug monograph for complete and up-to-date information.
